South Korea approves AstraZeneca COVID-19 vaccine for use
February 10, 2021Research and Development AstraZeneca, COVID-19
South Korea is to grant first approval for the Oxford University-AstraZeneca vaccine later today, with the rollout expected to start …
FDA approves Sanofi’s Libtayo for advanced basal cell carcinoma
February 10, 2021Research and Development Cancer, FDA, Sanofi
The FDA has approved Sanofi’s PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the first immunotherapy indicated for patients with advanced basal cell …
Janssen announces positive Phase III results for prostate cancer drug apalutamide
February 10, 2021Research and Development Cancer, Janssen
Final results from Janssen’s Phase III TITAN study have shown its cancer drug apalutamide improved overall survival (OS) in patients …
Takeda’s breast cancer treatment approved in Scotland
February 9, 2021Manufacturing and Production Takeda, breast cancer
The Scottish Medicines Consortium has accepted Takeda’s PROSTAP 3 DCS (leuprorelin acetate) treatment for use in patients with early and …
WHO backs AstraZeneca vaccine against South African variant
February 9, 2021Manufacturing and Production COVID-19, WHO, vaccines
World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …
AbbVie’s rheumatoid arthritis drug Rinvoq approved for NHS Scotland
February 9, 2021Manufacturing and Production AbbVie, rheumatoid arthritis
The Scottish Medicines Consortium (SMC) has recommended AbbVie’s rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for use on the NHS in …
ViiV’s HIV drug Rukobia gets EC marketing authorisation
February 9, 2021Manufacturing and Production HIV, ViiV
The European Commission (EC) has authorised ViiV Healthcare’s Rukobia (fostemsavir) 600mg extended-release tablets for use in combination with other antiretroviral …
Janssen’s esketamine nasal spray gets Europe approval for new indication
February 9, 2021Manufacturing and Production Europe, Janssen
The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered with oral antidepressant therapy in …
Merck, Pfizer, and 4D pharma join forces for bladder cancer clinical trial
February 8, 2021Sales and Marketing Cancer, Merck, Pfizer
A clinical trial collaboration between 4D pharma, Merck, and Pfizer to treat locally advanced or metastatic urothelial carcinoma (UC), also …
Researchers make neuroblastoma drug target discovery
February 8, 2021Sales and Marketing Cancer, GOSH, neuroblastoma
Scientists conducting the largest single cell study to date of the childhood cancer neuroblastoma have made a breakthrough in identifying …
CureVac enters collaboration with UK government on coronavirus variant vaccines
February 8, 2021Sales and Marketing COVID-19, CureVac
CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …
South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns
February 8, 2021Sales and Marketing AstraZeneca, COVID-19
AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …
South Korea approves Celltrion’s COVID-19 treatment Regdanvimab for emergency use
February 8, 2021Sales and Marketing COVID-19, celltrion
The South Korean Ministry of Food and Drug Safety (MFDS) has granted a conditional marketing authorisation (CMA) for the emergency …
Pharmafile.com’s top 10 news stories of the week
February 5, 2021Medical Communications COVID-19
In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …
New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October
February 5, 2021Medical Communications AstraZeneca, COVID-19
Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …
Pfizer withdraws application for emergency vaccine authorisation in India
February 5, 2021Medical Communications COVID-19, Pfizer
Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …
Hyloris and Purna Female Healthcare partner to develop novel women’s health product
February 5, 2021Medical Communications Hyloris, women
Hyloris Pharmaceuticals and Purna Female Healthcare (PFH), a spin-off founded by Purna Pharmaceuticals and Creafund, have entered into a partnership …
AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial
February 5, 2021Medical Communications AstraZeneca, Cancer
AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …
Destiny Pharma appoints Professor Mark Wilcox to its Scientific Advisory Board
February 4, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening …
Scripps Research and IAVI report positive findings from HIV vaccine Phase I trial
February 4, 2021HIV
Scripps Research and IAVI have returned positive Phase I results in their hunt for a HIV vaccine, detecting a targeted …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
